(Q38085020)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23444927%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23444927%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23444927%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Prokar Dasgupta

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23444927%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Jai H Seth

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23444927%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Mohammad S Khan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23444927%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Frank van der Aa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23444927%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Dirk de Ridder

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23444927%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Jalesh N Panicker

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23444927%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Clare J Fowler

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23444927%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

1 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23444927%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23444927%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23444927%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23444927%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

372-380

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23444927%20AND%20SRC:MED&resulttype=core&format=json

The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Basic mechanisms of urgency: roles and benefits of pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Urinary nerve growth factor levels in overactive bladder syndrome and lower urinary tract disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Beyond neurons: Involvement of urothelial and glial cells in bladder function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Decrease in bladder overactivity with REN1820 in rats with cyclophosphamide induced cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Effect of hyaluronic acid on urine nerve growth factor in cyclophosphamide-induced cystitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Bladder overactivity and hyperexcitability of bladder afferent neurons after intrathecal delivery of nerve growth factor in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Increased urinary nerve growth factor as a predictor of persistent detrusor overactivity after bladder outlet obstruction relief in a rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Effect of botulinum toxin on expression of nerve growth factor and transient receptor potential vanilloid 1 in urothelium and detrusor muscle of rats with bladder outlet obstruction-induced detrusor overactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Suppression of detrusor-sphincter dyssynergia by immunoneutralization of nerve growth factor in lumbosacral spinal cord in spinal cord injured rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Biomarkers: Potential Uses and Limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Increased urine and serum nerve growth factor levels in interstitial cystitis suggest chronic inflammation is involved in the pathogenesis of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Stretch-activated signaling of nerve growth factor secretion in bladder and vascular smooth muscle cells from hypertensive and hyperactive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Urinary nerve growth factor level is correlated with the severity of neurological impairment in patients with cerebrovascular accident

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Urinary neurotrophic factors in healthy individuals and patients with overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Urinary nerve growth factor but not prostaglandin E2 increases in patients with interstitial cystitis/bladder pain syndrome and detrusor overactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Correlation of urinary nerve growth factor level with pathogenesis of overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Nerve growth factor and prostaglandins in the urine of female patients with overactive bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

Changes of urinary nerve growth factor and prostaglandins in male patients with overactive bladder symptom.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11672.X

10.1111/J.1464-410X.2012.11672.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23444927%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference